eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

SCImago Journal & Country Rank
 
5/2004
vol. 3
 
Share:
Share:
more
 
 
abstract:

Tibolonw in hormone replacement therapy (part 2)

Artur J. Jakimiuk
,
Jacek Tomaszewski
,
Michał Bogusiewicz

Prz Menopauz 2004; 5: 6-13
Online publish date: 2004/10/22
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Since over 40 years hormone replacement therapy (HRT) is a standard treatment for menopausal symptoms. Quality of life improvement caused by the use of HRT was regarded to be beneficial for bone and cardiovascular system. However, recent studies showed that the prolonged use of HRT may be associated with increased risk of breast cancer. Moreover, HERS and WHI trials changed accepted opinion on use of hormone therapy in the primary and secondary prevention of cardiovascular diseases. Tibolone, a drug acting by a unique mechanism, since 1988 has been widely usded in over 70 countries. This review presents contemporary data on the effect of tibolone on the hot flushes, mood, sexual function and uterus.
keywords:

menopause, hormone replacement therapy, tibolone

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe